Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
LAMOTRIGINE
Milpharm Limited
N03AX09
LAMOTRIGINE
50 Milligram
Dispersable Tablet
Product subject to prescription which may be renewed (B)
Other antiepileptics
Authorised
2011-07-29
PACKAGE LEAFLET: INFORMATION FOR THE USER _ _ LAMOTRIGINE AUROBINDO 5 MG DISPERSIBLE/CHEWABLE TABLETS LAMOTRIGINE AUROBINDO 25 MG DISPERSIBLE/CHEWABLE TABLETS LAMOTRIGINE AUROBINDO 50 MG DISPERSIBLE/CHEWABLE TABLETS LAMOTRIGINE AUROBINDO 100 MG DISPERSIBLE/CHEWABLE TABLETS LAMOTRIGINE AUROBINDO 200 MG DISPERSIBLE/CHEWABLE TABLETS Lamotrigine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Lamotrigine Aurobindo is and what it is used for 2. What you need to know before you take Lamotrigine Aurobindo 3. How to take Lamotrigine Aurobindo 4. Possible side effects 5. How to store Lamotrigine Aurobindo 6. Contents of the pack and other information 1. WHAT LAMOTRIGINE AUROBINDO IS AND WHAT IT IS USED FOR Lamotrigine belongs to a group of medicines called anti-epileptics. It is used to treat two conditions – EPILEPSY and BIPOLAR DISORDER. LAMOTRIGINE AUROBINDO TREATS EPILEPSY by blocking the signals in the brain that trigger epileptic seizures (fits). For adults and children aged 13 years and over, Lamotrigine Aurobindo can be used on its own or with other medicines, to treat epilepsy. Lamotrigine Aurobindo can also be used with other medicines to treat the seizures that occur with a condition called Lennox-Gastaut syndrome. For children aged bet Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lamotrigine Aurobindo 50 mg dispersible/chewable tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each Lamotrigine Aurobindo 50 mg dispersible/chewable tablet contains 50 mg lamotrigine. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Dispersible/chewable tablet White to off-white, rounded square shaped uncoated tablets debossed with ‘H’ on multifaceted side and ‘79’ on flat side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Epilepsy: _Adults and adolescents aged 13 years and above_ Adjunctive or monotherapy treatment of partial seizures and generalised seizures, including tonic-clonic seizures. Seizures associated with Lennox-Gastaut syndrome. Lamotrigine is given as adjunctive therapy but may be the initial antiepileptic drug (AED) to start with in Lennox-Gastaut syndrome. _Children and adolescents aged 2 to 12 years_ Adjunctive treatment of partial seizures and generalised seizures, including tonic-clonic seizures and the seizures associated with Lennox-Gastaut syndrome. Monotherapy of typical absence seizures. Bipolar disorder: _Adults aged 18 years and above_ Prevention of depressive episodes in patients with bipolar I disorder who experience predominantly depressive episodes (see section 5.1). Lamotrigine Aurobindo is not indicated for the acute treatment of manic or depressive episodes. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Lamotrigine Aurobindo dispersible/chewable tablets may be chewed, dispersed in a small volume of water (at least enough to cover the whole tablet) or swallowed whole with a little water. If the calculated dose of lamotrigine (for example for treatment of children with epilepsy or patients with hepatic impairment) does not equate to whole tablets, the do Read the complete document